This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dr. Eric Krauland, PhD
President and Chief Scientific Officer at Adimab
Speaker

Profile

Dr. Eric Krauland is the Chief Scientific Officer and President of Adimab and has been with the company for 16 years. Dr. Krauland has worked in numerous roles at Adimab since 2007 and was a key contributor in the development of Adimab's platform. He received his PhD in Biological Engineering from the Massachusetts Institute of Technology in 2007 and his BS/MSE in Biomedical Engineering from Johns Hopkins University.

Agenda Sessions

  • Novel anti-CD3 Heavy chain-only Antibodies for Use in T-cell Engaging Multispecific Therapeutics

    13:45